The role of G-proteins and G-protein-coupledreceptors in human disease
DOI:
https://doi.org/10.61173/d7dc6a45Abstract
In human diseases associated with G protein, changes in abnormal content and distribution of multiple signaling
molecules and abnormal signaling pathways play critical roles in pathophysiological pathways. Abnormal information
transmission and signaling pathways are common channels in the pathogenesis of G protein diseases. G protein-coupled
receptors (GPCRs) are the largest group of membrane receptor proteins and represent the most common therapeutic
targets for drugs. This paper uses liver injury, blood pressure regulation, Parkinson’s disease, and some cancers to
illustrate the pathogenic mechanism and pathway-related treatment of G-protein and GPCR.
References
[1] Venkatakrishnan AJ, Deupi X, Lebon G, Tate CG, Schertler GF, Babu MM. Molecular signatures of G-protein-coupled receptors. Nature. 2013 Feb 14;494(7436):185-94. doi: 10.1038/ nature11896. PMID: 23407534.
[2] Davenport AP, Scully CCG, de Graaf C, Brown AJH, Maguire JJ. Advances in therapeutic peptides targeting G protein-coupled receptors. Nat Rev Drug Discov. 2020 Jun;19(6):389-413. doi: 10.1038/s41573-020-0062-z. Epub 2020 Mar 19. PMID: 32494050.
[3] Lee SM, Booe JM, Pioszak AA. Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs. Eur J Pharmacol. 2015 Sep 15;763(Pt B):196-205. doi: 10.1016/j.ejphar.2015.05.013. Epub 2015 May 14. PMID: 25981303; PMCID: PMC4584177.
[4] Flor PJ, Acher FC. Orthosteric versus allosteric GPCR activation:The great challenge of group-III mGluRs.Biochem Pharmacol, 2012, 84(4):414–424.
[5] Herraiz C, JournéF, Abdel-Malek Z, Ghanem G, JiménezCervantes C, García-Borrón JC. Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogenactivated protein kinases involves transactivation of cKIT.Mol Endocrinol, 2011, 25(1):138–156.
[6] Schöneberg T, Liebscher I. Mutations in G Protein-Coupled Receptors: Mechanisms, Pathophysiology and Potential Therapeutic Approaches. Pharmacol Rev. 2021 Jan;73(1):89- 119. doi: 10.1124/pharmrev.120.000011. PMID: 33219147.
[8] Zhang MY, Zhu L, Zheng X, Xie TH, Wang W, Zou J, Li Y, Li HY, Cai J, Gu S, Yao Y, Wei TT. TGR5 Activation Ameliorates Mitochondrial Homeostasis via Regulating the PKCδ/Drp1- Dean&Francis HK2 Signaling in Diabetic Retinopathy. Front Cell Dev Biol. 2022 Jan 14;9:759421. doi: 10.3389/fcell.2021.759421. PMID: 35096809; PMCID: PMC8795816.
[9] Karkoulias G, McCrink KA, Maning J, Pollard CM, Desimine VL, Patsouras N, Psallidopoulos M, Taraviras S, Lymperopoulos A, Flordellis C. Sustained GRK2-dependent CREB activation is essential for α-adrenergic receptor-induced PC12 neuronal differentiation. Cell Signal. 2020 Feb;66:109446. doi: 10.1016/j.cellsig.2019.109446. Epub 2019 Oct 31. PMID: 31678682.2
[10] Zhang H, Yang S, Wang J, Jiang Y. Blockade of AMPK- Mediated cAMP-PKA-CREB/ATF1 Signaling Synergizes with Aspirin to Inhibit Hepatocellular Carcinoma. Cancers (Basel). 2021 Apr 6;13(7):1738. doi: 10.3390/cancers13071738. PMID: 33917483; PMCID: PMC8038809.
[11] Bahrami S, Drabløs F. Gene regulation in the immediateearly response process. Adv Biol Regul. 2016 Sep;62:37-49. doi: 10.1016/j.jbior.2016.05.001. Epub 2016 May 13. PMID: 27220739.
[12] Nairn AC, Picciotto MR. Calcium/calmodulin-dependent protein kinases. Semin Cancer Biol. 1994 Aug;5(4):295-303. PMID: 7803766.
[13] Williams JP, Micoli K, McDonald JM. Calmodulin-an often-ignored signal in osteoclasts. Ann N Y Acad Sci. 2010 Mar;1192(1):358-64. doi: 10.1111/j.1749-6632.2009.05242.x. PMID: 20392260; PMCID: PMC2940234.
[14] Soderling TR. CaM-kinases: modulators of synaptic plasticity. Curr Opin Neurobiol. 2000 Jun;10(3):375-80. doi: 10.1016/s0959-4388(00)00090-8. PMID: 10851169.
[15] Maruyama T, Tanaka K, Suzuki J, Miyoshi H, Harada N, Nakamura T, Miyamoto Y, Kanatani A, Tamai Y. Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/ M-Bar) in mice. J Endocrinol. 2006 Oct;191(1):197-205. doi: 10.1677/joe.1.06546. PMID: 17065403.
[16] Vassileva G, Golovko A, Markowitz L, Abbondanzo SJ, Zeng M, Yang S, Hoos L, Tetzloff G, Levitan D, Murgolo NJ, Keane K, Davis HR Jr, Hedrick J, Gustafson EL. Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. Biochem J. 2006 Sep 15;398(3):423-30. doi: 10.1042/ BJ20060537. PMID: 16724960; PMCID: PMC1559456.
[21] Keitel V, Häussinger D. TGR5 in cholangiocytes. Curr Opin Gastroenterol. 2013 May;29(3):299-304. doi: 10.1097/ MOG.0b013e32835f3f14. PMID: 23429467.
[22] Wang C, Zhu C, Shao L, Ye J, Shen Y, Ren Y. Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease. Mediators Inflamm. 2019 Jun 24;2019:7659509. doi: 10.1155/2019/7659509. PMID: 31341422; PMCID: PMC6613006.
[23] Liu H, Pathak P, Boehme S, Chiang JL. Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis. J Lipid Res. 2016 Oct;57(10):1831-1844. doi: 10.1194/jlr.M069807. Epub 2016 Aug 17. PMID: 27534992; PMCID: PMC5036364.
[24] Lee YS, Lee C, Choung JS, Jung HS, Jun HS. Glucagon- Like Peptide 1 Increases β-Cell Regeneration by Promoting αto β-Cell Transdifferentiation. Diabetes. 2018 Dec;67(12):2601- 2614. doi: 10.2337/db18-0155. Epub 2018 Sep 26. PMID: 30257975.
[25] Shapiro H, Kolodziejczyk AA, Halstuch D, Elinav E. Bile acids in glucose metabolism in health and disease. J Exp Med. 2018 Feb 5;215(2):383-396. doi: 10.1084/jem.20171965. Epub 2018 Jan 16. PMID: 29339445; PMCID: PMC5789421.wssss
[26] Keitel V, Häussinger D. Role of TGR5 (GPBAR1) in Liver Disease. Semin Liver Dis. 2018 Nov;38(4):333-339. doi: 10.1055/s-0038-1669940. Epub 2018 Oct 24. PMID: 30357770.
[27] Reich M, Spomer L, Klindt C, Fuchs K, Stindt J, Deutschmann K, Höhne J, Liaskou E, Hov JR, Karlsen TH, Beuers U, Verheij J, Ferreira-Gonzalez S, Hirschfield G, Forbes SJ, Schramm C, Esposito I, Nierhoff D, Fickert P, Fuchs CD, Trauner M, García-Beccaria M, Gabernet G, Nahnsen S, Mallm JP, Vogel M, Schoonjans K, Lautwein T, Köhrer K, Häussinger D, Luedde T, Heikenwalder M, Keitel V. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis. J Hepatol. 2021 Sep;75(3):634-646. doi: 10.1016/j.jhep.2021.03.029. Epub 2021 Apr 17. PMID: 33872692.
[28] Hanson SM, Cleghorn WM, Francis DJ, Vishnivetskiy SA, Raman D, Song X, Nair KS, Slepak VZ, Klug CS, Gurevich VV. Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity. J Mol Biol. 2007 Apr 27;368(2):375- 87. doi: 10.1016/j.jmb.2007.02.053. Epub 2007 Feb 22. PMID: 17359998; PMCID: PMC1904837.
[29] Erdtmann-Vourliotis M, Mayer P, Ammon S, Riechert U, Höllt V. Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain. Brain Res Mol Brain Res. 2001 Nov 1;95(1-2):129-37. doi: 10.1016/s0006- 8993(01)03046-3. PMID: 11687284.
[30] Greengard P. The neurobiology of slow synaptic transmission. Science. 2001 Nov 2;294(5544):1024-30. doi: 10.1126/science.294.5544.1024. PMID: 11691979.
[31] Aubert I, Ghorayeb I, Normand E, Bloch B. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum. J Comp Neurol. 2000 Feb 28;418(1):22-32. PMID: 10701753.
[33] Gainetdinov RR, Bohn LM, Sotnikova TD, Cyr M, Laakso A, Macrae AD, Torres GE, Kim KM, Lefkowitz RJ, Caron MG, Premont RT. Dopaminergic supersensitivity in G proteincoupled receptor kinase 6-deficient mice. Neuron. 2003 Apr 24;38(2):291-303. doi: 10.1016/s0896-6273(03)00192-2. PMID: 12718862.
[35] Wu N, Song L, Yang X, Yuan W, Liu Z. NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and β-arrestin-1 expression in parkinsonian rats. Clin Interv Aging. 2013;8:347-52. doi: Dean&Francis 10.2147/CIA.S41464. Epub 2013 Mar 26. PMID: 23569367; PMCID: PMC3615843.
[36] Feldman RD, Gros R. Regulator of G-protein signaling-2 as a candidate gene: the road to hypertension or just another roadside marker? Hypertension. 2006 Mar;47(3):337-8. doi: 10.1161/01.HYP.0000200748.73303.a6. Epub 2006 Jan 23. PMID: 16432040.
[37] Yang J, Kamide K, Kokubo Y, Takiuchi S, Tanaka C, Banno M, Miwa Y, Yoshii M, Horio T, Okayama A, Tomoike H, Kawano Y, Miyata T. Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population. J Hypertens. 2005 Aug;23(8):1497-505. doi: 10.1097/01.hjh.0000174606.41651.ae. PMID: 16003176.
[38] Duan X, Zhou Y, Teng X, Tang C, Qi Y. Endoplasmic reticulum stress-mediated apoptosis is activated in vascular calcification. Biochem Biophys Res Commun. 2009 Oct 2;387(4):694-9. doi: 10.1016/j.bbrc.2009.07.085. Epub 2009 Jul 19. PMID: 19622343.
[39] Chang JR, Duan XH, Zhang BH, Teng X, Zhou YB, Liu Y, Yu YR, Zhu Y, Tang CS, Qi YF. Intermedin1-53 attenuates vascular smooth muscle cell calcification by inhibiting endoplasmic reticulum stress via cyclic adenosine monophosphate/protein kinase A pathway. Exp Biol Med (Maywood). 2013 Oct;238(10):1136-46. doi: 10.1177/1535370213502619. Epub 2013 Sep 4. PMID: 24006303.
[40] Tang X, Jin R, Qu G, Wang X, Li Z, Yuan Z, Zhao C, Siwko S, Shi T, Wang P, Xiao J, Liu M, Luo J. GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway. Cancer Res. 2013 Oct 15;73(20):6206-18. doi: 10.1158/0008-5472.CAN-13- 1049. Epub 2013 Sep 5. PMID: 24008316.
[42] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313. PMID: 30207593.
[45] Kamińska K, Czarnecka AM, Escudier B, Lian F, Szczylik C. Interleukin-6 as an emerging regulator of renal cell cancer. Urol Oncol. 2015 Nov;33(11):476-85. doi: 10.1016/ j.urolonc.2015.07.010. Epub 2015 Aug 18. PMID: 26296264.
[46] Gudbrandsdottir G, Aarstad HH, Bostad L, Hjelle KM, Aarstad HJ, Bruserud Ø, Tvedt THA, Beisland C. Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC). Cancer Immunol Immunother. 2021 Jan;70(1):19-30. doi: 10.1007/s00262-020-02655-z. Epub 2020 Jul 3. PMID: 32621022; PMCID: PMC7838134.
[47] Onnis B, Fer N, Rapisarda A, Perez VS, Melillo G. Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cells. J Clin Invest. 2013 Apr;123(4):1615-29. doi: 10.1172/JCI59623. Epub 2013 Mar 15. PMID: 23549086; PMCID: PMC3613900.
[50] Sakaguchi T, Yoshino H, Sugita S, Miyamoto K, Yonemori M, Osako Y, Meguro-Horike M, Horike SI, Nakagawa M, Enokida H. Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma. Oncotarget. 2018 May 1;9(33):23003-23017. doi: 10.18632/ oncotarget.25190. PMID: 29796168; PMCID: PMC5955408.
[51] Wang L, Lau JS, Patra CR, Cao Y, Bhattacharya S, Dutta S, Nandy D, Wang E, Rupasinghe CN, Vohra P, Spaller MR, Mukhopadhyay D. RGS-GAIP-interacting protein controls breast cancer progression. Mol Cancer Res. 2010 Dec;8(12):1591- 600. doi: 10.1158/1541-7786.MCR-10-0209. Epub 2010 Oct 27. PMID: 21047775; PMCID: PMC3850212.
[52] Deeble PD, Murphy DJ, Parsons SJ, Cox ME. Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells. Mol Cell Biol. 2001 Dec;21(24):8471-82. doi: 10.1128/MCB.21.24.8471- 8482.2001. PMID: 11713282; PMCID: PMC100010.
[53] Anderson KC, Dalton WS. Synopsis of a research roundtable presented on cell signaling in myeloma: regulation of growth and apoptosis--opportunities for new drug discovery. Mol Cancer Ther. 2002 Dec;1(14):1361-5. PMID: 12516971.
[54] Lin CZ, Ma HT, Zou SX, Wang GJ, Chen WH, Han ZK. [Effect of soy isoflavones on cAMP/PKA pathway in breast cancer cells of the rat.]. Sheng Li Xue Bao. 2005 Aug 25;57(4):517-22. Chinese. PMID: 16094502.
[55] Ahn S, Olive M, Aggarwal S, Krylov D, Ginty DD, Vinson C. A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol Cell Biol. 1998 Feb;18(2):967-77. doi: 10.1128/ MCB.18.2.967. PMID: 9447994; PMCID: PMC108809.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
